MEDICAMEN BIOTECH . Q3 FY25 Results

MEDICAMEN BIOTECH . has released its financial results for the Q3 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:

Revenue Analysis

• Current Quarter Revenue: Rs. 45.14 Cr
• Quarter-on-Quarter (QoQ) Change: 0.89% (Previous Quarter: Rs. 44.74 Cr )
• Year-on-Year (YoY) Change: -2.92% (Same Quarter Last Year: Rs. 46.50 Cr )

Profitability Metrics

• Net Profit: Rs. 2.92 Cr
• QoQ Profit Change: 223.27% (Previous Quarter: Rs. 0.90 Cr )
• YoY Profit Change: 43.95% (Same Quarter Last Year: Rs. 2.03 Cr )

Shareholder Returns

• Earnings Per Share (EPS): Rs. 2.30
• QoQ EPS Change: 223.94% (Previous Quarter: Rs. 0.71)
• YoY EPS Change: 43.75% (Same Quarter Last Year: Rs. 1.60)

Performance Summary

Mixed

MEDICAMEN BIOTECH . had a complex financial situation. Different parts of the business are performing differently, showing a changing market.

This analysis provides a snapshot of MEDICAMEN BIOTECH .'s financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.